Trial Profile
An open label, controlled, randomized, parallel-group study to evaluate the effects of lercanidipine versus amlodipine in hypertensive patients with cerebral ischemic stroke
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Lercanidipine (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 24 Nov 2015 New trial record